Literature DB >> 6165811

Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue.

D D Bigner, O M Pitts, C J Wikstrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6165811     DOI： 10.3171/jns.1981.55.1.0032

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  27 in total

Review 1.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

2.  EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.

Authors:  Manabu Hatano; Junichi Eguchi; Tomohide Tatsumi; Naruo Kuwashima; Jill E Dusak; Michel S Kinch; Ian F Pollack; Ronald L Hamilton; Walter J Storkus; Hideho Okada
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

Review 3.  DCVax®-L--developed by Northwest Biotherapeutics.

Authors:  Stavros Polyzoidis; Keyoumars Ashkan
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Authors:  David A Reardon; Duane A Mitchell
Journal:  Semin Immunopathol       Date:  2017-01-30       Impact factor: 9.623

Review 5.  Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.

Authors:  Adam M Swartz; Qi-Jing Li; John H Sampson
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Acute hemorrhagic leukoencephalomyelitis in a man with viral myocarditis.

Authors:  Indira D Kitulwatte; Patrick J H Kim; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2015-07-08       Impact factor: 2.007

Review 7.  Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme.

Authors:  Alia Hdeib; Andrew Edward Sloan
Journal:  CNS Oncol       Date:  2015

8.  Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

Authors:  J H Sampson; G E Archer; D M Ashley; H E Fuchs; L P Hale; G Dranoff; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 9.  Dendritic cell vaccines for brain tumors.

Authors:  Won Kim; Linda M Liau
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

10.  Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy.

Authors:  Anne Clavreul; Isabelle Jean; Laurence Preisser; Agnès Chassevent; Anne Sapin; Sophie Michalak; Philippe Menei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.